MASSACHUSETTS GENERAL HOSPITAL
Molecular subtyping of brain tumors using a blood-based multiplexed assay
Molecular subtyping of brain tumors using a blood-based multiplexed assay is a funding opportunity from MASSACHUSETTS GENERAL HOSPITAL, up to 637162, closing March 31, 2030.
Mar 31, 2030
(1339d left)Overview
SUMMARY Gliomas are typically characterized by high malignancy and poor prognosis. The most recent WHO classification of CNS neoplasms has advanced the diagnostic framework to stratify disease by incorporating tumor histological features and genetic/molecular mutations. The current standard of diagnosis and monitoring…